Latest Developments in Global Anesthesia And Respiratory Devices Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Anesthesia And Respiratory Devices Market

  • Healthcare
  • Apr 2025
  • Global
  • 350 Pages
  • No of Tables: 50
  • No of Figures: 250

  • In September 2024, Knack Global announced the acquisition of Merrick Management, Inc., a provider of revenue cycle management solutions for anesthesia practices. This acquisition marks a significant expansion of Knack’s offerings into the anesthesia market, with Merrick’s experienced management team expected to play a pivotal role in leading Knack’s newly formed Anesthesia Services division, which will enhance Knack’s market position
  • In June 2024, GHR Healthcare acquired United Anesthesia, a CRNA and Anesthesiologist staffing firm based in North Carolina, U.S. This strategic merger is expected to allow GHR Healthcare to expand its service offerings and provide comprehensive healthcare staffing solutions to clients nationwide, further strengthening its presence in the anesthesia staffing industry
  • In January 2024, GlaxoSmithKline (GSK) strategically acquired Aiolos Bio, a biopharmaceutical company focused on innovative asthma treatments. Aiolos Bio's advanced pipeline of therapies for respiratory and inflammatory conditions offered GSK promising opportunities for growth and enhanced patient care, positioning the company for future success in the respiratory treatment market
  • In October 2023, AirLife, a leading manufacturer and distributor of medical devices for anesthesia and respiratory care in North America, announced the completion of its acquisition of the respiratory business, including the BALLARD, MICROCUFF, and endOclear product lines, from Avanos Medical, Inc. This acquisition enables AirLife to enhance its product portfolio, offering a wider range of anesthesia and respiratory care solutions to the market
  • In June 2023, Avanos Medical, Inc. agreed to sell its Regenerative Medicine (RH) business to SunMed Group Holdings, LLC (SunMed), a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care. This sale marks a shift in Avanos’ business strategy, allowing SunMed to strengthen its position in the anesthesia and respiratory device market
  • In March 2023, SunMed, a leading North American manufacturer and distributor of medical devices for anesthesia and respiratory care, announced a definitive agreement with Vyaire Medical, under which SunMed will acquire Vyaire’s business, which manufactures and sells respiratory and anesthesia supplies for airway management and surgical treatment. This acquisition further enhances SunMed's portfolio and solidifies its leadership in the anesthesia and respiratory care space